Better Coronavirus Stock: Novavax or Vaxart?

Better Coronavirus Stock: Novavax or Vaxart?

Both Moderna and Pfizer have brought coronavirus vaccines to market, but there still are plenty of opportunities to bet on players that haven't yet brought their vaccines across the finish line. Novavax (NASDAQ: NVAX) and Vaxart (NASDAQ: VXRT) are in just this situation. In the fall, Novavax launched a phase 3 study, while Vaxart began its phase 1 trial.